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ZebraﬁshLeo1 is a component of the Polymerase-Associated Factor 1 (PAF1) complex, an evolutionarily conserved
protein complex involved in gene transcription regulation and chromatin remodeling. The role of leo1 in
vertebrate embryogenesis has not previously been examined. Here, we report that zebraﬁsh leo1 encodes a
nuclear protein that has a similar molecular structure to Leo1 proteins from other species. From a genetic
screen, we identiﬁed a zebraﬁsh mutant defective in the leo1 gene. The truncated Leo1LA1186 protein lacks a
nuclear localization signal and is distributed mostly in the cytoplasm. Phenotypic analysis showed that while
the initial patterning of the primitive heart tube is not affected in leo1LA1186 mutant embryos, the differ-
entiation of cardiomyocytes at the atrioventricular boundary is aberrant, suggesting a requirement for Leo1
in cardiac differentiation. In addition, the expression levels of markers for neural crest-derived cells such as
crestin, gch2, dct and mitfa are greatly reduced in leo1LA1186 mutants, indicating a requirement for Leo1 in
maintaining the neural crest population. Consistent with this ﬁnding, melanocyte and xanthophore popu-
lations are severely reduced, craniofacial cartilage is barely detectable, andmbp-positive glial cells are absent
in leo1LA1186 mutants after three days of development. Taken together, these results provide the ﬁrst genetic
evidence of the requirement for Leo1 in the development of the heart and neural crest cell populations.ll and Developmental Biology,
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Embryonic developmental processes are controlled spatially
and temporally by precise genetic programs. In addition to tissue-
speciﬁc transcription factors, tightly regulated transcriptional controls
involving the recruitment of RNA polymerase II-associated initiation
and elongation complexes are required for the initiation of mRNA
synthesis and the stability of nascent transcripts. The subsequent
recruitment of other RNA polymerase II-associated complexes such as
the Srb-Mediator complex or Polymerase-Associated Factor (PAF1)
complex promotes chromatin remodeling which further affects
transcription efﬁciency.
While the roles of tissue-speciﬁc transcription factors required
for regulating cardiac development have been studied extensively,
mechanisms by which global transcription regulatory complexes and
chromatin remodeling proteins inﬂuence cardiac differentiation are
just being discovered. The important roles of general transcription
complex components in cardiac development have been exempliﬁedby studies of the zebraﬁsh mutants pandora (pan/spt6) and foggy
(fog/spt5). Spt6 and Spt5 are elongation factors associated with RNA
Polymerase II following the initiation of transcriptional elongation.
Both pan and fog mutant embryos display normal expression of the
early cardiac markers gata4 and nkx2.5, but terminal differentiation of
myocardial precursors is severely affected (Yelon et al., 1999; Keegan
et al., 2002), demonstrating a critical regulatory role for general
transcription factors in cardiac development.
The PAF1 complex consists of ﬁve evolutionarily conserved
proteins: Paf1, Ctr9, Leo1, Rtf1, and Cdc73 (Mueller and Jaehning,
2002; Rozenblatt-Rosen et al., 2005; Adelman et al., 2006). The PAF1
complex has been shown to associate with RNA polymerase II,
transcription elongation factors and chromatin remodeling proteins
(Shi et al., 1996, 1997; Mueller and Jaehning, 2002; Krogan et al.,
2003; Simic et al., 2003), but the precise requirements of individual
PAF1 complex components in development are just being evaluated.
In yeast, mutants deﬁcient in members of the PAF1 complex exhibit
pleiotropic phenotypes and changes in a subset of transcripts,
indicative of general transcription defects (Betz et al., 2002; Mueller
and Jaehning, 2002). Loss of function of Arabidopsis homologs of Paf1
and Ctr9 results in an early ﬂowering phenotype due to a reduction in
histone H3methylation (He et al., 2004; Oh et al., 2004). InDrosophila,
RNAi-mediated knockdown of Rtf1 enhances the wing phenotype in
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expression levels of Cdc73 homologues modulate Wnt and Hh
signaling (Mosimann et al., 2006, 2009). Similarly, loss of function
of Rtf1 and Ctr9 in zebraﬁsh results in a host of developmental defects
including cardiogenesis abnormalities, a reduction of the neural crest
population, and reduced Notch signaling in the developing somites
(Akanuma et al., 2007). Furthermore, patients carrying mutations in
the human CDC73 homologue (the Hyperparathyroidism-jaw tumor
syndrome tumor suppressor gene HRPT2) suffer from parathyroid
tumors and kidney cysts among other defects (Carpten et al., 2002).
Whether mutations in other components of the PAF1 complex are
causative to other congenital defects or diseases is not yet known.
Unlike other PAF1 complex proteins, loss of Leo1 function in
yeast causes no obvious phenotypes (Magdolen et al., 1994; Mueller
and Jaehning, 2002), and the requirements for Leo1 in vertebrate
development have not previously been investigated. Here we report
the isolation of a zebraﬁsh leo1mutant from a genetic screen designed
to identify genes critical for heart development. The leo1LA1186mutant
embryos have dysmorphic hearts and severely reduced blood cir-
culation due to a differentiation defect in cardiomyocytes particularly
at the atrioventricular boundary. In addition, neural crest-derived
tissues such as pigment cells, glial cells and craniofacial cartilage are
severely reduced in leo1LA1186 mutant embryos. Overexpression of
wild-type leo1 mRNA in leo1LA1186 mutant embryos suppresses the
defects in both cardiac and neural crest-derived tissues, providing the
ﬁrst genetic evidence that Leo1 is essential for the development of
the heart and neural crest cells in vertebrates.
Materials and methods
Zebraﬁsh husbandry and ENU mutagenesis
Male ﬁsh of the Tg(kdr:GFP)LA116 line were mutagenized with ENU
as previously described (Mullins et al., 1994; Solnica-Krezel et al.,
1994; Choi et al., 2007). LA1186 mutants were identiﬁed based on
their cardiac defects from a screen that surveyed 900 mutagenized
genomes. Zebraﬁsh colonies were cared for and bred under standard
conditions and developmental stages of zebraﬁsh embryos were
determined using standard morphological features of ﬁsh raised at
28.5 °C (Westerﬁeld, 2000).
Positional cloning
LA1186 heterozygotes were crossed to the polymorphic WIK strain
to generate a hybrid line for mapping. Embryos used for mapping were
lysed in embryo lysis buffer (10 mMTris pH8.0, 2 mMEDTA, 0.2% Triton
X-100, 100 µg/ml Proteinase K) at 55 °C overnight to obtain genomic
DNA.GenomicDNA from24embryos (wild-typeormutant)waspooled
and used for bulk segregant analysis with a panel of 200 microsatellite
markers designed at the Cardiovascular Research Center of the
Massachusetts General Hospital (Michelmore et al., 1991; Mably et al.,
2003). Primer sequences of the custommarkers 18-839-3 and 18-189-5
are: 18-839-3-F, 5′-TACAAACACTGGCACGCCATTAC; 18-839-3-R, 5′-
ACTTGCTGTGGGGATTGCAGT; 18-189-5-F, 5′-CCAGATCATTTGTGTGT-
CACTATG; and 18-189-5-R, 5′-CTTGGAGCCAATAAATCATTTGTA.
Total RNA was isolated from 1 day post fertilization (dpf) LA1186
mutants and their wild-type siblings using RNA Wiz (Ambion) and
cDNA was synthesized using the Superscript II Kit (Invitrogen). cDNA
fragments were ampliﬁed with Phusion polymerase (Finnzymes) and
cloned into pCR-Blunt II-TOPO (Invitrogen) for sequencing.
Constructs and injections
The leo1 cDNA constructs were ampliﬁed from 1 dpf wild-type
embryo cDNA using Phusion polymerase (Finnzymes) and cloned
into pCS2+3XFLAG for tagging with the FLAG epitope. The plasmidswere cut with NotI and SP6 RNA polymerase was used to generate
mRNA for injection. For rescue experiments, embryos from a cross
of LA1186/+ ﬁsh were injected with 75 pg leo1 mRNA or leo1LA1186
mRNA at the one-cell stage.
Histology
Fixed embryos were dehydrated, embedded in plastic blocks (JB-4,
Polysciences), sectioned at 10 μm and stained with 0.1% methylene
blue as previously described (Chen and Fishman, 1996).
Whole mount in situ hybridization
Embryos for in situ hybridization were raised in embryo medium
supplemented with 0.2 mM 1-phenyl-2-thiourea to maintain optical
transparency (Westerﬁeld, 2000). Whole mount in situ hybridization
was performed as described previously (Chen and Fishman, 1996). The
antisense RNA probes used in this study include leo1, nkx2.5, cmlc2
(myl7), vmhc, amhc (myh6), bmp4, notch1b, wnt2bb, versican (vcana),
crestin, mbp, snai1b, sox9b, foxd3, sox10, dct, gch2, mitfa, tbx1,
endothelin-1, fkd2, pax2, and hand2. Wnt2bb was ampliﬁed from 2
dpf wild-type embryo cDNA by PCR with Phusion polymerase
(Finnzymes) and cloned into pCR-Blunt II-TOPO (Invitrogen). The
plasmidwas linearizedwithNotI and SP6 RNApolymerasewas used to
generate antisense riboprobe.
Antibody staining
Embryos injected with RNA encoding FLAG-tagged zebraﬁsh leo1
(100 pg) were ﬁxed in 4% PFA in PBS at 75% epiboly. The ﬁxed
embryos were incubated in primary antibody (1:50 mouse anti-FLAG
M2 (Sigma)) in blocking solution (10% goat serum in PBDT) for 2 h at
room temperature followed by detection with ﬂuorescent secondary
antibody (1:200 anti-mouse IgG1-R (Santa Cruz Biotechnology)).
Stained embryos were embedded in 1% low-melt agarose and imaged
on a Zeiss LSM510 confocal microscope equipped with a 63× water
objective.
Alcian blue staining
Embryos were ﬁxed in 4% PFA in PBST after three days of devel-
opment. Staining was carried out as previously described (Golling
et al., 2002). In brief, embryos were stained with 0.1% Alcian blue
solution dissolved in 50% ethanol/0.1 M HCL for 2 h. After staining,
embryos were rinsed in ethanol and rehydrated gradually into PBST,
before being transferred into 0.05% trypsin solution dissolved in
saturated sodium tetraborate for 3 h. Embryos were then bleached in
1% KOH/3% H2O2 for 1 h.
Results
To identify genes critical for cardiac development, we conducted
an ethylnitrosourea mutagenesis screen. From this screen we found a
mutant, designated LA1186, that exhibits a dysmorphic and dysfunc-
tional heart. The primitive heart tube forms normally in LA1186
mutants and the expression of multiple early cardiac markers, in-
cluding nkx2.5 and cmlc2, are indistinguishable between LA1186
mutant embryos and their wild-type siblings (Figs. 1D–G). However,
by 30 h post fertilization (hpf), LA1186 hearts exhibit reduced con-
tractility. As a result, a cardiac edema occurs and the outﬂow tract,
sinus venosus, and ventricle collapse by 2 days post fertilization (dpf)
(Fig. 1I). These ﬁndings suggest that LA1186 is required for
maintaining the proper function and morphology of the embryonic
heart, but is not involved in the initial steps of cardiac speciﬁcation or
heart tube elongation.
Fig. 1. Loss of Leo1 function results in cardiac abnormalities and absence of pigmentation (A, B, C) Lateral view of a two-day-old wild-type embryo (A), a leo1LA1186 mutant (B) and a
leo1LA1186 mutant injected with wild-type leo1 mRNA (C). (D, E, F, G) Dorsal view. Expression patterns of cardiac markers, nkx2.5 (D, E) and cmlc2 (F, G), are indistinguishable
between wild-type siblings (D, F) and leo1LA1186 mutants (E, G) at the 10 somite stage and 24 h post fertilization, respectively. (H, I) Histological sections. In contrast to wild-type
hearts (H), the cardiac chambers of leo1LA1186 mutants are collapsed by 2 dpf (I). o, outﬂow tract; v, ventricle; a, atrium; sv, sinus venosus.
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a severe reduction in both black (melanophores) and yellow
(xanthophores) pigment cells after two days of development
(Fig. 1B) and a severe defect in the formation of the jaw after three
days of development (Fig. 6), indicating that LA1186 is required for
the formation of pigment cells and craniofacial structures as well.
To assess whether the phenotypes observed in LA1186 mutants are
merely the result of developmental delay, we analyzed the develop-
ment of several other organ systems at 2 dpf. We found that the
morphogenesis of the brain, otic vesicles, pronephric ducts, thyroid,
liver, pancreas, and trunk vasculature are normal in LA1186 mutants
at 2 dpf (Supplementary Fig. 1), suggesting that they are not
developmentally delayed compared to wild-type embryos.
LA1186 encodes Leo1, a PAF1 complex protein
As the ﬁrst step toward identifying the molecular lesion of LA1186,
we mapped LA1186 to zebraﬁsh linkage group 18 between marker
z8343 and the custom marker 18-189-5. We then generated addi-
tional custom markers in this region and detected no recombination
between LA1186 and marker 18-839-3 in 1600 meiosis, indicating a
genetic distance of less than 0.06 cM between LA1186 and 18-839-3
(Fig. 2A). The leo1 gene is in close proximity to 18-839-3, making it a
good candidate gene for LA1186. We ampliﬁed the coding region
of leo1 from LA1186 mutant embryos and their wild-type siblings.
Sequencing analysis revealed a C to T transition at nucleotide 1744
that produces a premature stop codon in LA1186 mutant embryos
(Fig. 2B), suggesting that the nonsense mutation in leo1 may be
responsible for the cardiac, pigmentation and craniofacial defects
observed in LA1186.
Transcripts of leo1 can be detected in wild-type embryos by whole
mount in situ hybridization analysis as early as the 6-somite (S) stage.
During the segmentation stage, leo1 transcripts are present in a wide
range of tissues (Figs. 3B,C,E,F). The expression of leo1 becomes re-
stricted to the eyes, brain, pharyngeal arches, and anterior somites by24 hpf, and the transcripts of leo1 are no longer detectable by in situ
hybridization in zebraﬁsh embryos by 48 hpf (Figs. 3G,H and data not
shown). No signiﬁcant reduction of leo1 signal was noted in LA1186
mutant embryos (data not shown), suggesting that leo1LA1186 tran-
scripts are not subject to nonsense-mediated decay.
Leo1 is a component of the PAF1 complex, which is associated with
RNA polymerase II in the nucleus and has an important role in
transcription regulation (Betz et al., 2002; Mueller and Jaehning,
2002). The premature stop codon in LA1186 truncates Leo1 prior to its
putative nuclear localization sequence (Fig. 2C) and may thereby
disturb nuclear localization of Leo1LA1186. To examine the subcellular
localization of Leo1, we tagged Leo1wt and Leo1LA1186 with FLAG
epitopes and injected these constructs into wild-type embryos at the
1-cell stage. As expected, FLAG-Leo1wt is localized to the nucleus,
while FLAG-Leo1LA1186 is present predominantly in the cytoplasm
(Figs. 2D–G). Given the previously described role of the PAF1 complex
during transcription, the inability of Leo1LA1186 to localize to the
nucleus would likely impair the function of the Leo1 mutant protein.
To further evaluate the causative relationship between loss of
Leo1 activity and the LA1186 phenotypes, we injected leo1mRNA into
one-cell stage embryos collected from a cross of LA1186 hetero-
zygotes. All embryos from the LA1186 heterozygous cross that were
injected with 75 pg of leo1 mRNA had normal jaw and cardiac mor-
phology and normal levels of pigmentation (n=180) (Fig. 1C), even
though genotyping these embryos with marker 18-939-3 indicated
that one quarter were homozygous for LA1186. On the contrary,
injection of leo1LA1186 mRNA to embryos collected from a LA1186
heterozygous cross was unable to rescue LA1186 mutant phenotypes
(data not shown). These ﬁndings indicate that the Leo1LA1186 protein
is not functional and demonstrate that wild-type leo1 mRNA is suf-
ﬁcient to rescue both cardiac and pigmentation phenotypes in LA1186
mutant embryos. Furthermore, overexpression of leo1LA1186 transcript
in wild-type or LA1186 heterozygotes did not result in any noticeable
morphological defects (data not shown), suggesting that Leo1LA1186 is
not acting as a dominant-negative protein in mutant embryos.
Fig. 2. Positional cloning of Leo1LA1186. (A) LA1186wasmapped to linkage group 18 between markers z8343 and 18-189-5. No recombinants were detected between LA1186 and the
custommarker 18-839-3 from 1600meioses. Asteriskmarks the position of the nonsensemutation. (B) Sequencing of the leo1 locus inwildtype and LA1186 embryos identiﬁed a C to
T transition, resulting in a premature stop codon (*). (C) Schematic diagram of the molecular structure of leo1. Zebraﬁsh Leo1WT contains a Leo1 domain (green), nuclear localization
sequence (red), and an aspartic acid-rich tail (dark blue). The Leo1LA1186 protein is truncated prior to the nuclear localization sequence. (D, E, F, G) Cellular localization of Leo1WT and
Leo1LA1186. FLAG-tagged Leo1WT (D) colocalized with DAPI (E) in the nucleus. FLAG-tagged Leo1LA1186 was detected mostly in the cytoplasm (F, G). FLAG, red; DAPI, blue.
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of similarity to yeast Leo1 (55%) and other vertebrate Leo1 proteins
(N70%) (Supplementary Fig. 2). As with all the Leo1 proteins
analyzed, the zebraﬁsh Leo1 protein contains a unique Leo1 domainFig. 3. In situ analysis of leo1mRNA expression. (A–F) Leo1 transcripts are detected inmany ti
in the brain, pharyngeal arches and eyes and tapers posteriorly in the somites. (A, B, C, E, Gand a putative nuclear localization sequence. In addition, zebraﬁsh
Leo1 contains an aspartic acid-rich C-terminal region that is not
present in the yeast, mouse and human Leo1 proteins (Fig. 2C and
Supplementary Fig. 2). To determine whether this C-terminal tail wasssues beginning from the 6S to the 20S stage. (G–H) At 24 hpf, leo1 is strongly expressed
) Lateral view. (D, E, F, H) Anterior dorsal view.
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zebraﬁsh Leo1 protein lacking sequences after amino acid 647. We
injected the transcripts generated from this truncated Leo1 construct
into embryos collected from an LA1186 heterozygous cross and found
that the truncated protein was able to rescue the LA1186 mutant
phenotype (n=69), suggesting that the aspartic acid-rich tail is not
necessary for Leo1 activity.
Leo1 is required for the differentiation of the atrioventricular boundary
of the heart
LA1186 mutant hearts are unable to establish proper circulation,
which is often associated with abnormal morphology and cardiac
gene expression in zebraﬁsh. Indeed, the sinus venosus, outﬂow tract,
and ventricle are collapsed in 2 dpf leo1LA1108 mutants (Fig. 1I). We
utilized several cardiac markers to assess whether leo1LA1108 mutant
hearts differentiate properly. We found that while the atrial marker,
amhc, is properly expressed in the atrium, the expression domain of
the ventricular marker, vmhc, is expanded to the atrium (Figs. 4A–D),
suggesting a defect in the regionalization of cardiac chamber-speciﬁc
genes. The differentiation defects of the cardiomyocytes are most
prominent at the atrioventricular (AV) boundary. In wild-type hearts,
expression of bmp4, versican and wnt2bb is restricted to myocardial
cells at the AV boundary after two days of development. In leo1Fig. 4. Cardiac differentiation phenotypes of leo1LA1186. Normally, vmhc expression is restricte
mutants (B). Expression of amhc, however, is restricted properly to the atrial chamber in bot
the endocardium at the AV boundary of wild-type embryos (E), but are absent in leo1LA1186
myocardium of the AV boundary in wild-type embryos. Both bmp4 (H) and versican (J) tra
mutant embryos (L). Dashed lines (in A–D) and arrows (in E, G, I, K) mark the boundary omutant hearts, the expression levels of bmp4, versican andwnt2bb are
greatly reduced and the expression domains of bmp4 and versican are
no longer restricted to the AV boundary (Figs. 4G–L). Furthermore,
expression of notch1b in endocardial cells at the AV boundary is
absent in leo1 mutant hearts (Fig. 4F). Taken together, these data
indicate an important role for Leo1 in cardiac differentiation, espe-
cially for those cells located at the AV boundary.
Leo1 is required for the development of neural crest cells
Leo1mutant embryos exhibit a severe reduction in both the mela-
nophore and xanthophore pigment cell populations after two days of
development (Fig. 1B). To further investigate the pigmentation
defects in leo1 embryos, we examined the expression of gch2, dct,
and mitfa (markers for xanthophores (Knight et al., 2004), melano-
phores (Lamason et al., 2005) and early melanoblasts (Hong et al.,
2005), respectively), at 1 dpf. Consistent with the loss of melano-
phores and xanthophores in 2-day-old leo1LA1186 mutant embryos,
we found that the expression levels of these markers were greatly
reduced in leo1LA1186 mutant embryos after one day of development,
suggesting that Leo1 may regulate the differentiation of pigment cells
(Fig. 5).
In addition, after three days of development defects in craniofacial
formation become apparent in leo1LA1186 mutant embryos. Stainingd in the ventricle in wild-type embryos (A), but is expanded into the atrium in leo1LA1186
h wild-type (C) and leo1LA1186 mutant embryos (D). Notch1b transcripts are detected in
mutants (F). Expression of bmp4 (G), versican (I), and wnt2bb (K) are detected in the
nscripts are no longer restricted in leo1LA1186 mutants, while wnt2bb is not detected in
f atrium and ventricle.
Fig. 5. Pigmentation phenotypes of leo1LA1186. (A, B)Gch is expressed in xanthophores of the head and trunk (A). Expression levels of gch are reduced in leo1LA1186mutants (B). (C, D)Dct, a
marker for differentiatedmelanophores, is severely reduced in leo1LA1186mutants (D) compared towild-type siblings (C). (E, F)Mitfa transcripts are detected in earlymelanoblasts along
the head and trunk (E). Leo1LA1186 mutants display a reduction inmitfa expression (F).
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arches are completely absent and only remnants of trabeculae cranii
remain in 3-day-old leo1LA1186mutant embryos (Figs. 6A–D). By 5 dpf,
a very reduced craniofacial skeleton has formed in leo1LA1186 mutants
(Supplementary Fig. 3). However, the expression of tbx1 and
endothelin-1, markers for the pharyngeal arch epithelium and meso-
dermal core (Piotrowski et al., 2003), are unaffected in leo1 mutant
embryos (Figs. 6E–H). These ﬁndings indicate that Leo1 activity is not
required for the formation of the epithelium or the mesodermal core
of the pharyngeal arches, but is required for the differentiation of an
appropriate number of craniofacial chondrocytes, or the proliferation
or survival of these cells.
Melanophores, xanthophores and the cartilaginous component
of the craniofacial skeleton are derived from neural crest cells (Kelsh
et al., 1996; Kimmel et al., 2001; Barrallo-Gimeno et al., 2004;
Montero-Balaguer et al., 2006). Another cell type that neural crest
cells are known to contribute to in zebraﬁsh are glia of the peripheral
nervous system (PNS) (Kelsh et al., 2000). To determine if Leo1 is also
required for PNS glial cell development, we examined the expression
of the glial marker myelin basic protein (mbp) in wild-type and
leo1LA1186 mutant embryos. Wild-type embryos display mbp expres-
sion in cranial glia of the CNS and the Schwann cells of the trunk.
Interestingly, no mbp positive cells were detected in leo1LA1186
mutants after 3 and 5 days of development, indicating a complete
loss of both cranial and trunk glia (Supplementary Fig. 4). The loss of
peripheral glia (Schwann cells) is consistent with the notion that the
development of neural crest-derived tissues is defective in leo1LA1186mutants and the loss of CNS glia suggests that Leo1 may play a role
in the development of glia in addition to its function in neural crest
development.
The loss of multiple neural crest-derived cell types in leo1LA1186
mutant embryos suggests that Leo1 may be required for neural crest
speciﬁcation and/or differentiation. To determine if Leo1 is required
for the initial speciﬁcation of the neural crest cell population, we
evaluated the expression pattern of early neural crest markers. We
found that the expression patterns of pre-migratory neural crest
markers (sox9b, sox10, foxd3, and snai1b; (Barrallo-Gimeno et al.,
2004; Hong et al., 2005; Yan et al., 2005)) are indistinguishable
betweenwild-type and leo1LA1186 embryos at the 10S stage, indicating
that neural crest cells are properly speciﬁed in leo1LA1186 mutant
embryos (Supplementary Fig. 5). Furthermore, we detected no
signiﬁcant changes in the expression of the pharyngeal arch neural
crest markers dlx2 (Figs. 7A,B) and hand2 (data not shown) in
leo1LA1186 mutant embryos at the 18S stage, suggesting that the
reduction of the craniofacial skeleton is not due to an absence of
neural crest progenitors, but rather the inability of a sufﬁcient number
of these cells to develop into craniofacial chondrocytes (Hong et al.,
2005). Interestingly, at both the 12S stage and 24 hpf, the expression
level of the pan-neural crest marker crestin is reduced in leo1LA1186
mutant embryos (Figs. 7C–J). We also noted that the loss of crestin
expression is most severe in the cranial neural crest region, the
population of neural crest cells anterior to the otic vesicle. Further-
more, we could barely detect any crestin-positive cells in the cranial
neural crest region at the 12S stage and only residual crestin-positive
Fig. 6. Craniofacial phenotypes of leo1LA1186. (A, B, C, D) Alcian blue staining of wild-type (A, C) and leo1LA1186 embryos (B, D) at 3 days post fertilization. Leo1LA1186 exhibit severe
craniofacial defects including absence of the ethmoid plate from the anterior neurocranium and complete loss of pharyngeal arches. (A, B) Lateral view. (C, D) Ventral view. ANC,
anterior neurocranium; t, trabecular cranii; m, mandibular arch; h, hyoid arch; P3–7, pharyngeal arches 3–7. (E, F, G, H) Tbx1 and endothelin-1 (edn-1) expression patterns in the
pharyngeal arch epithelium and mesenchymal core are indistinguishable between wild-type embryos (E, G) and leo1LA1186 mutants (F, H) at 27 hpf.
Fig. 7.Development of neural crest cells is dependent upon Leo1 function. (A, B) Dorsal anterior viewof dlx2 expression in pharyngeal arch neural crest at the 18S stage. The expression
pattern of dlx2 is normal inwild-type (A) and leo1LA1186 embryos (B). (C–J) Pan-neural crestmarker, crestin, at the 12 somite stage (C–F) and 24hpf (G–J). Crestin expression is detected
in anterior and trunk neural crest of wild-type embryos (C, E, G, I), but is severely reduced in the region anterior to the otic vesicle of leo1LA1186mutants (D, F, H, J). (C, D, G, H) Lateral
view. (E, F, I, J) Dorsal anterior view.
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these data suggest that Leo1 is not required for the initial speciﬁcation
of neural crest cells, but is required for their subsequent development
into derivatives such as pigment cells and craniofacial cartilage.
Discussion
From a forward genetic screen, we isolated the zebraﬁsh LA1186
mutant exhibiting abnormalities in cardiac development as well as
craniofacial defects and a reduction in pigmentation. Subsequent
molecular cloning showed that the LA1186 locus encodes Leo1, a
component of the PAF1 complex. Consistentwith previous ﬁndings that
the PAF1 complex is associatedwith RNA polymerase II and plays a role
in chromatin remodeling (Shi et al., 1996, 1997; Mueller and Jaehning,
2002; Krogan et al., 2003), the Leo1 protein is localized to the nucleus,
and this nuclear localization is required for its biological function. The
requirements for Leo1 in the development of multi-cellular organisms,
however, have not been previously examined. Our study shows that the
leo1LA1186 mutation is embryonic lethal, indicating that Leo1 is an
essential gene for vertebrates. Our phenotypic analysis of leo1LA1186
mutant embryos further reveals defects in the differentiation of the
heart, especially at the AV boundary, and the development of neural
crest-derived tissues, providing the ﬁrst genetic evidence for the
requirements of Leo1 in vertebrate development.
The PAF1 complex is an evolutionarily conserved protein com-
plex. A large number of biochemical studies in yeast and cultured
mammalian cells have shown that the PAF1 complex consists of
Paf1, Ctr9, Rtf1, Cdc73 and Leo1(Mueller and Jaehning, 2002;
Rozenblatt-Rosen et al., 2005; Adelman et al., 2006). In zebraﬁsh,
embryos lacking the activity of Ctr9 or Rtf1 have defects in a wide
range of tissues including the heart and neural crest cells (Akanuma
et al., 2007). The similarity of the defects in heart development and
neural crest-derived tissues among leo1, rtf1 and ctr9 mutants and
morphants is in agreement with the fact that these proteins are
members of the same protein complex. However, while the cardiac
and neural crest phenotypes of ctr9 and rtf1 morphants are highly
similar (Akanuma et al., 2007), the effect of loss of leo1 function
is signiﬁcantly milder, suggesting that each component of the
PAF1 complex may be differentially required for various biological
processes. This notion is further supported by the ﬁndings that
embryos deﬁcient in Ctr9 and Rtf1 are small and have pleiotropic
defects. It has been carefully documented that both ctr9 morphants
and rtf1 mutants are defective in somite and otic vesicle formation
in addition to the aforementioned cardiac and neural crest abnor-
malities (Akanuma et al., 2007). The leo1LA1186 mutant embryos, on
the contrary, exhibit normal body size and have defects that are
restricted to the heart and some neural crest-derived tissues. Future
studies on the precise requirements of each component of the PAF1
complex would provide insights into mechanisms by which the
PAF1 complex regulates vertebrate development.
Leo1 mutant embryos have a severe reduction of craniofacial car-
tilage, melanophores, and xanthophores indicating a requirement for
Leo1 activity in neural crest-derived tissues. The expression patterns
of all early neural crest markers analyzed are normal in leo1LA1186
mutant embryos suggesting that the speciﬁcation of neural crest cells
is not affected. However, the severe decrease in the expression of dct,
gch and mitfa in leo1LA1186 mutants suggests that Leo1 may be impor-
tant for the survival or differentiation of neural crest cells. The loss of
function of Leo1 affects a subset of anterior neural crest cells most
severely. When analyzing the expression of crestin, a member of a
family of retroelements that is expressed in neural crest cells in
zebraﬁsh (Rubinstein et al., 2000), we found that while the overall
crestin expression level is reduced in leo1LA1186 mutant embryos,
crestin expression is barely detectable in the region anterior to the otic
vesicle. This observation is consistent with the severe loss of cra-
niofacial cartilage observed in leo1LA1186 mutant embryos. Interest-ingly, the expression of other neural crest markers, such as dlx2 and
hand2, is indistinguishable between leo1LA1186 mutant embryos and
their wild-type siblings suggesting that the neural crest population
does exist in the anterior region of leo1mutant embryos. It is possible
that Leo1 directly regulates the expression of crestin and other, as of
yet unknown, genes that are critical for the development of neural
crest-derived cell types, especially in the population of neural crest
cells located anterior to the otic vesicle. Alternatively, the anterior
neural crest might consist of crestin-positive and crestin-negative
populations, with the formation of the crestin-positive neural crest
cell population requiring Leo1 activity. Furthermore, if two distinct
neural crest cell populations exist, our ﬁnding that the craniofacial
cartilage formation is severely defective even though a substantial
amount of dlx2 and hand2-positive, crestin-negative neural crest cells
remain in leo1LA1186 mutant embryos would suggest that crestin-
positive neural crest cells are major contributors to the cartilage
component of the craniofacial skeleton.
Leo1 is also required for proper cell differentiation in the heart. The
initial patterning of the primitive heart tube appears normal in
leo1LA1186 mutant embryos as evidenced by their normal morphology
and the proper expression pattern of multiple cardiac markers ana-
lyzed. However, the heart begins to show signs of dysmorphism and
dysfunction after 30 hpf. Genes that are normally expressed in car-
diomyocytes at the AV boundary, such as bmp4 and versican fail to be
properly regionalized and the expression of wnt2bb is absent in
leo1LA1186 mutant hearts, indicating an essential role for Leo1 in the
differentiation of cardiomyocytes. The mechanisms underlying the
cardiac differentiation defect observed in leo1LA1186 embryos are not
yet clear. It is conceivable that the failure of the AV boundary to be
properly regionalized in leo1LA1186 mutants is secondary to defects in
cardiac contractility, since proper cardiac function is required for
normal gene expression and cellular morphology of the AV boundary
endocardium (Bartman et al., 2004; Beis et al., 2005). Alternatively,
Leo1 may function as an intrinsic factor to drive cardiomyocyte dif-
ferentiation. One caveat of this possibility is that we have not been
able to detect signiﬁcant leo1 expression in the lateral plate meso-
derm and leo1 expression appeared to be excluded from the heart in
embryos 24 hpf and older. It is formally possible that the expression of
leo1 in cardiac progenitors or cardiomyocytes is below the level that
can be detected by whole mount in situ hybridization. However, a
more exciting possibility is that Leo1 inﬂuences heart development
via regulation of the differentiation of neural crest cells. In mouse
and chick, neural crest cells have a pivotal role in the development
of the cardiac outﬂow tract septum, aorticopulmonary septum, and
semilunar and atrioventricular valves (for review see (Hutson and
Kirby, 2003; Nakamura et al., 2006; Hutson and Kirby, 2007)). The
contribution of neural crest cells to the development of the two-
chambered zebraﬁsh heart is less well understood. Lineage studies
have demonstrated that a subset of neural crest cells (located in the
region from the midbrain–hindbrain boundary to the ﬁrst somite
at the 10-somite stage) migrate to the heart and differentiate into
cardiomyocytes in the outﬂow tract, ventricle, and AV boundary and
to a lesser extent, the atrium (Li et al., 2003; Sato and Yost, 2003).
Removal of these cells by laser ablation results in cardiac ventricular
dysfunction and failure of cardiac looping (Li et al., 2003). Intriguingly,
the differentiation of the anterior neural crest population, which
would include a substantial portion of cardiac neural crest, is most
affected in the leo1LA1186 mutant and the cardiac defects of the
leo1LA1186 mutants are similar to those observed in cardiac neural
crest-ablated embryos. Like cardiac neural crest-ablated embryos,
leo1LA1186 mutants exhibit reduced cardiac contractility shortly after
the heart begins to beat and subsequently develop pericardial edema
and abnormal cardiac looping. Further studies on the causative rela-
tionship between the neural crest and cardiac defects in leo1LA1186
mutant embryos using transgenic approaches to drive expression
of leo1 speciﬁcally in the neural crest may help to expand our
175C.T. Nguyen et al. / Developmental Biology 341 (2010) 167–175understanding of the role of neural crest contribution in zebraﬁsh
heart development.
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